Skip to Content

Tag: ViCentra


Also Noted

ViCentra raises $85M, preps for US entry

September 3, 2025HME News Staff

UTRECHT, the Netherlands — ViCentra, a European medical device company redefining insulin delivery for people with diabetes, has announced the successful close of an upsized $85 million Series D financing led by new investor Innovation Industries, with matching participation from existing investors Partners in Equity and Invest-NL and continued support from EQT Life Sciences and Health Innovations. With this fresh funding, ViCentra will accelerate manufacturing scale-up, launch the next-generation...

Diabetes, Insulin pump, ViCentra


Read Full Articlered right arrow icon